134 related articles for article (PubMed ID: 15093548)
1. Humoral immunity to immunodominant epitopes of Hepatitis C virus in individuals infected with genotypes 1a or 1b.
Carlos MP; Yamamura Y; Vu Q; Conzen K; Anderson DE; Torres JV
Clin Immunol; 2004 Apr; 111(1):22-7. PubMed ID: 15093548
[TBL] [Abstract][Full Text] [Related]
2. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of variable regions of hepatitis C virus proteins: selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA.
Rodr Guez-L Pez M; Riezu-Boj JI; Ruiz M; Berasain C; Civeira MP; Prieto J; Borr S-Cuesta F
J Gen Virol; 1999 Mar; 80 ( Pt 3)():727-738. PubMed ID: 10092013
[TBL] [Abstract][Full Text] [Related]
4. Cross-reactivity and clinical impact of the antibody response to hepatitis C virus second envelope glycoprotein (E2).
Hadlock KG; Gish R; Rowe J; Rajyaguru SS; Newsom M; Warford A; Foung SK
J Med Virol; 2001 Sep; 65(1):23-9. PubMed ID: 11505439
[TBL] [Abstract][Full Text] [Related]
5. Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies.
Muerhoff AS; Gutierrez R; Kyrk C; Leary T; Schlauder G; Dawson G; Desai SM
J Med Virol; 2008 Mar; 80(3):411-8. PubMed ID: 18205228
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.
Pujol FH; Khudyakov YE; Devesa M; León G; Blitz-Dorfman L; Monsalve F; Lambert SB; Kalinina TY; Liprandi F; Fields HA
Viral Immunol; 1996; 9(2):89-96. PubMed ID: 8822625
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies.
Mancini N; Canducci F; Carletti S; Berardinelli E; Serafini G; Grieco A; Perotti M; Malcangi G; Danieli MG; Varaldo PE; Clementi M; Burioni R
J Biol Regul Homeost Agents; 2003; 17(2):183-7. PubMed ID: 14518720
[TBL] [Abstract][Full Text] [Related]
8. Characterization of humoral and cell-mediated immune responses directed against hepatitis C virus F protein in subjects co-infected with hepatitis C virus and HIV-1.
Troesch M; Jalbert E; Canobio S; Boulassel MR; Routy JP; Bernard NF; Bruneau J; Lapointe N; Boucher M; Soudeyns H
AIDS; 2005 May; 19(8):775-84. PubMed ID: 15867491
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a multiple peptide assay for typing of antibodies to the hepatitis C virus: relation to genomic typing by the polymerase chain reaction.
Zhang ZX; Yun ZB; Chen M; Sönnerborg A; Sällberg M
J Med Virol; 1995 Jan; 45(1):50-5. PubMed ID: 7536231
[TBL] [Abstract][Full Text] [Related]
10. Identification of immunodominant epitopes in the core and non-structural region of hepatitis C virus by enzyme immunoassay using synthetic peptides.
Park HJ; Byun SM; Ha YJ; Ahn JS; Moon HM
J Immunoassay; 1995 May; 16(2):167-81. PubMed ID: 7543117
[TBL] [Abstract][Full Text] [Related]
11. Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients.
Missale G; Cariani E; Lamonaca V; Ravaggi A; Rossini A; Bertoni R; Houghton M; Matsuura Y; Miyamura T; Fiaccadori F; Ferrari C
Hepatology; 1997 Sep; 26(3):792-7. PubMed ID: 9303515
[TBL] [Abstract][Full Text] [Related]
12. Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing.
Walker A; Skibbe K; Steinmann E; Pfaender S; Kuntzen T; Megger DA; Groten S; Sitek B; Lauer GM; Kim AY; Pietschmann T; Allen TM; Timm J
J Virol; 2016 Jan; 90(1):33-42. PubMed ID: 26446603
[TBL] [Abstract][Full Text] [Related]
13. Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus.
Neville JA; Prescott LE; Bhattacherjee V; Adams N; Pike I; Rodgers B; El-Zayadi A; Hamid S; Dusheiko GM; Saeed AA; Haydon GH; Simmonds P
J Clin Microbiol; 1997 Dec; 35(12):3062-70. PubMed ID: 9399495
[TBL] [Abstract][Full Text] [Related]
14. Characterization of T-cell responses against immunodominant epitopes from hepatitis C virus E2 and NS4a proteins.
Sarobe P; Lasarte JJ; García N; Civeira MP; Borrás-Cuesta F; Prieto J
J Viral Hepat; 2006 Jan; 13(1):47-55. PubMed ID: 16364082
[TBL] [Abstract][Full Text] [Related]
15. Immune responses to hepatitis C virus structural and nonstructural proteins induced by plasmid DNA immunizations.
Gordon EJ; Bhat R; Liu Q; Wang YF; Tackney C; Prince AM
J Infect Dis; 2000 Jan; 181(1):42-50. PubMed ID: 10608749
[TBL] [Abstract][Full Text] [Related]
16. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
17. Limited humoral immunity in hepatitis C virus infection.
Chen M; Sällberg M; Sönnerborg A; Weiland O; Mattsson L; Jin L; Birkett A; Peterson D; Milich DR
Gastroenterology; 1999 Jan; 116(1):135-43. PubMed ID: 9869611
[TBL] [Abstract][Full Text] [Related]
18. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
[TBL] [Abstract][Full Text] [Related]
19. Patterns of immune responses to the host-encoded GOR and hepatitis C virus core-derived epitopes with relation to hepatitis C viremia, genotypes, and liver disease severity.
Quiroga JA; Pardo M; Navas S; Martín J; Carreño V
J Infect Dis; 1996 Feb; 173(2):300-5. PubMed ID: 8568289
[TBL] [Abstract][Full Text] [Related]
20. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
Chu CM; Sheen IS; Liaw YF
Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]